WASHINGTON, D.C.– The U.S. National Security Commission on Emerging Biotechnology issued its first report since its creation through the National Defense Authorization Act of FY2022. The bipartisan ...

Hong Kong Pharma Digital Technology Holdings Ltd. ( ($HKPD) ) has provided an update. At its annual general meeting on December 12, 2025, Cellyan ...

The National Security Commission on Emerging Biotechnology (NSCEB) delivered its major report and action plan to Congress in early April with a blunt message: the world is entering a new age driven by ...

Opinions expressed by Entrepreneur contributors are their own. The past three years have changed nearly every industry. Where business used to be conducted in person, in offices and laboratories, the ...

Using biological agents as weapons is illegal, but an organism that scientists lawfully use for genuine research could be repurposed for an attack. Therefore, what is banned depends on what an actor ...

French engineer-virologist Thomas Mollet examines cells infected with a Sars-CoV-2 virus at the Biosafety level 3 laboratory in Saint-Herblain, France. Jean-Francois Monier/AFP via Getty Images ...

And what a year it has been! Artificial intelligence is being incorporated into more aspects of our lives, weight-loss drugs ...

DUBLIN--(BUSINESS WIRE)--The "Royalty Rates in Pharmaceutical and Biotechnology Deals" report has been added to ResearchAndMarkets.com's offering. Royalty Rates in Pharmaceutical and Biotechnology ...

7investing.com’s resident biotech Ph.D., Dana Abramovitz, shares some valuable lessons about what to look for when investing in this space. Investing is challenging. There are all sorts of things to ...